Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2007Molecular Cancer Therapeutics

The power and promise of “rewiring” the mitogen-activated protein kinase network in prostate cancer therapeutics

View Full Paper
Ask AI
Bookmark
Share

Authors

APAthanasios PapatsorisNational and Kapodistrian University of AthensMKMichalis V. KaramouzisNational and Kapodistrian University of AthensAPAthanasios G. PapavassiliouNational and Kapodistrian University of Athens

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Papatsoris et al. (2007) studied this question.

synapsesocial.com/papers/6ab367caa3092c804b7239e9https://doi.org/10.1158/1535-7163.mct-06-0610
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of p38 by Vitamin D Reduces Interleukin-6 Production in Normal Prostate Cells via Mitogen-Activated Protein Kinase Phosphatase 5: Implications for Prostate Cancer Prevention by Vitamin D2006 · 202 citations
  2. 217-AAG: mechanisms of antitumour activity2005 · 18 citations
  3. 3Emerging views of integrin signaling: Implications for prostate cancer2003 · 66 citations